Jack Bendheim Sells 5,280 Shares of Phibro Animal Health (NASDAQ:PAHC) Stock

November 27, 2025 by InsiderTrades.com

Key Points

CEO Jack Bendheim sold 5,280 shares on Nov. 26 at an average $44.02 (~$232,426) and has executed multiple recent tranches, reducing his ownership by 13.5% to 33,840 shares valued at about $1.49M.
Quarterly results beat expectations: Phibro reported EPS of $0.73 versus a $0.58 consensus and revenue of $363.89M (vs. $345.44M), and set FY2026 guidance of 2.640–2.810 EPS.
The company declared a quarterly dividend of $0.12 (annualized $0.48, yield 1.1%; ex-dividend Nov. 26) and has a market cap of about $1.75B with a PE of 36.64.

Phibro Animal Health Corporation (NASDAQ:PAHC - Get Free Report) CEO Jack Bendheim sold 5,280 shares of Phibro Animal Health stock in a transaction dated Wednesday, November 26th. The shares were sold at an average price of $44.02, for a total value of $232,425.60. Following the completion of the transaction, the chief executive officer directly owned 33,840 shares of the company's stock, valued at $1,489,636.80. This represents a 13.50% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Jack Bendheim also recently made the following trade(s):

On Tuesday, November 25th, Jack Bendheim sold 7,040 shares of Phibro Animal Health stock. The shares were sold at an average price of $43.93, for a total transaction of $309,267.20.
On Monday, November 17th, Jack Bendheim sold 5,280 shares of Phibro Animal Health stock. The stock was sold at an average price of $44.56, for a total transaction of $235,276.80.
On Thursday, November 13th, Jack Bendheim sold 8,801 shares of Phibro Animal Health stock. The shares were sold at an average price of $44.47, for a total transaction of $391,380.47.
On Wednesday, November 12th, Jack Bendheim sold 21,536 shares of Phibro Animal Health stock. The shares were sold at an average price of $45.23, for a total transaction of $974,073.28.
On Monday, November 10th, Jack Bendheim sold 38,303 shares of Phibro Animal Health stock. The stock was sold at an average price of $45.29, for a total transaction of $1,734,742.87.
On Friday, November 7th, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The shares were sold at an average price of $42.86, for a total value of $150,867.20.
On Tuesday, November 4th, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The shares were sold at an average price of $43.10, for a total value of $151,712.00.
On Thursday, October 30th, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The shares were sold at an average price of $41.07, for a total value of $144,566.40.
On Tuesday, October 28th, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The shares were sold at an average price of $41.56, for a total value of $146,291.20.
On Thursday, October 23rd, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The stock was sold at an average price of $40.18, for a total value of $141,433.60.

Phibro Animal Health Stock Performance

Phibro Animal Health stock opened at $43.23 on Thursday. The company has a market cap of $1.75 billion, a PE ratio of 36.64, a PEG ratio of 1.24 and a beta of 0.81. The company has a current ratio of 2.76, a quick ratio of 1.25 and a debt-to-equity ratio of 2.46. Phibro Animal Health Corporation has a 1 year low of $16.16 and a 1 year high of $46.42. The company's 50-day moving average is $40.89 and its two-hundred day moving average is $33.18.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last posted its quarterly earnings results on Wednesday, November 5th. The company reported $0.73 earnings per share for the quarter, topping analysts' consensus estimates of $0.58 by $0.15. Phibro Animal Health had a net margin of 3.73% and a return on equity of 32.14%. The business had revenue of $363.89 million during the quarter, compared to the consensus estimate of $345.44 million. Phibro Animal Health has set its FY 2026 guidance at 2.640-2.810 EPS. Equities analysts anticipate that Phibro Animal Health Corporation will post 1.95 earnings per share for the current year.

Phibro Animal Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, December 17th. Stockholders of record on Wednesday, November 26th will be given a $0.12 dividend. This represents a $0.48 annualized dividend and a dividend yield of 1.1%. The ex-dividend date is Wednesday, November 26th. Phibro Animal Health's dividend payout ratio (DPR) is currently 28.92%.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on PAHC shares. Weiss Ratings reiterated a "buy (b-)" rating on shares of Phibro Animal Health in a report on Monday. Bank of America increased their price target on shares of Phibro Animal Health from $19.00 to $27.00 and gave the company an "underperform" rating in a research report on Friday, August 29th. Zacks Research cut shares of Phibro Animal Health from a "strong-buy" rating to a "hold" rating in a report on Monday, November 10th. Morgan Stanley set a $34.00 target price on shares of Phibro Animal Health in a report on Thursday, August 28th. Finally, JPMorgan Chase & Co. lifted their price target on shares of Phibro Animal Health from $45.00 to $50.00 and gave the stock an "overweight" rating in a research report on Friday, November 7th. Two research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and two have issued a Sell rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Hold" and an average price target of $31.40.

Read Our Latest Stock Analysis on Phibro Animal Health

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the stock. Vanguard Group Inc. boosted its holdings in shares of Phibro Animal Health by 0.4% in the first quarter. Vanguard Group Inc. now owns 1,521,520 shares of the company's stock valued at $32,500,000 after buying an additional 6,784 shares during the period. Acadian Asset Management LLC lifted its position in Phibro Animal Health by 0.5% in the 1st quarter. Acadian Asset Management LLC now owns 782,939 shares of the company's stock valued at $16,713,000 after acquiring an additional 4,144 shares in the last quarter. Geode Capital Management LLC boosted its stake in Phibro Animal Health by 1.4% in the 2nd quarter. Geode Capital Management LLC now owns 554,927 shares of the company's stock worth $14,175,000 after purchasing an additional 7,841 shares during the period. Nuveen LLC bought a new position in Phibro Animal Health during the 1st quarter worth about $10,312,000. Finally, Invesco Ltd. raised its stake in shares of Phibro Animal Health by 92.3% in the 1st quarter. Invesco Ltd. now owns 387,739 shares of the company's stock valued at $8,282,000 after purchasing an additional 186,087 shares during the period. Institutional investors own 99.34% of the company's stock.

Phibro Animal Health Company Profile

(Get Free Report)

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.